×
ADVERTISEMENT

JULY 28, 2021

Acute Respiratory Distress Syndrome Management in COVID–19 Patients

Jolien Segers, MD1
Oliver De Fre, MD1
Imré Van Herreweghe, MD1
Sam Van Boxstael, MD1
Dina-Aina Zukic2 Jill Vanhaeren2
1 ZOL Hospital, Genk, Belgium
2 Research Associate, NYSORA (New York School of Regional Anesthesia) New York City
The authors reported no relevant financial disclosures.

 Download the printer-friendly PDF version here.


Acute respiratory distress syndrome (ARDS) is a life–threatening condition due to an acute and diffuse inflammation of the lung tissues.

Introduction: